110 related articles for article (PubMed ID: 18362844)
1. Iterative exposure of clonal BRIN-BD11 cells to ninhydrin enables selection of robust toxin-resistant cells but with decreased gene expression of insulin secretory function.
Liu HK; McCluskey JT; McClenghan NH; Flatt PR
Pancreas; 2008 Apr; 36(3):294-301. PubMed ID: 18362844
[TBL] [Abstract][Full Text] [Related]
2. Streptozotocin-resistant BRIN-BD11 cells possess wide spectrum of toxin tolerance and enhanced insulin-secretory capacity.
Liu HK; McCluskey JT; McClenghan NH; Flatt PR
Endocrine; 2007 Aug; 32(1):20-9. PubMed ID: 17992598
[TBL] [Abstract][Full Text] [Related]
3. Effects of cytotoxic agents on functional integrity and antioxidant enzymes in clonal beta-cells.
Picton SF; McCluskey JT; Flatt PR; McClenaghan NH
Diabetes Metab; 2002 Dec; 28(6 Pt 2):3S70-7; discussion 3S108-12. PubMed ID: 12688636
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine-induced impairment of insulin secretion from clonal pancreatic BRIN-BD11 beta-cells is not prevented by catalase.
Patterson S; Flatt PR; McClenaghan NH
Pancreas; 2007 Jan; 34(1):144-51. PubMed ID: 17198197
[TBL] [Abstract][Full Text] [Related]
5. L-Alanine induces changes in metabolic and signal transduction gene expression in a clonal rat pancreatic beta-cell line and protects from pro-inflammatory cytokine-induced apoptosis.
Cunningham GA; McClenaghan NH; Flatt PR; Newsholme P
Clin Sci (Lond); 2005 Nov; 109(5):447-55. PubMed ID: 16045439
[TBL] [Abstract][Full Text] [Related]
6. Costus pictus D. Don leaf extract stimulates GLP-1 secretion from GLUTag L-cells and has cytoprotective effects in BRIN-BD11 β-cells.
Patibandla C; Khan ZI; MacGregor L; Campbell MJ; Patterson S
J Ethnopharmacol; 2020 Oct; 260():112970. PubMed ID: 32422353
[TBL] [Abstract][Full Text] [Related]
7. Amylase-Dependent Regulation of Glucose Metabolism and Insulin/Glucagon Secretion in the Streptozotocin-Induced Diabetic Pig Model and in a Rat Pancreatic Beta-Cell Line, BRIN-BD11.
Pierzynowska K; Oredsson S; Pierzynowski S
J Diabetes Res; 2020; 2020():2148740. PubMed ID: 33294459
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of the glucose-sensing mechanism in the clonal insulin-secreting BRIN-BD11 cell line.
McClenaghan NH; Elsner M; Tiedge M; Lenzen S
Biochem Biophys Res Commun; 1998 Jan; 242(2):262-6. PubMed ID: 9446781
[TBL] [Abstract][Full Text] [Related]
9. Prolonged exposure to homocysteine results in diminished but reversible pancreatic beta-cell responsiveness to insulinotropic agents.
Patterson S; Scullion SM; McCluskey JT; Flatt PR; McClenaghan NH
Diabetes Metab Res Rev; 2007 May; 23(4):324-34. PubMed ID: 17089371
[TBL] [Abstract][Full Text] [Related]
10. Effects of the imidazoline binding site ligands, idazoxan and efaroxan, on the viability of insulin-secreting BRIN-BD11 cells.
Gao H; Mourtada M; Morgan NG
JOP; 2003 May; 4(3):117-24. PubMed ID: 12743417
[TBL] [Abstract][Full Text] [Related]
11. Expression and functional roles of guanylate cyclase isoforms in BRIN-BD11 β-cells.
Russell MA; Morgan NG
Islets; 2010; 2(6):374-82. PubMed ID: 21099339
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of homocysteine toxicity to insulin-secreting BRIN-BD11 cells in combination with alloxan.
Scullion SM; Gurgul-Convey E; Elsner M; Lenzen S; Flatt PR; McClenaghan NH
J Endocrinol; 2012 Aug; 214(2):233-8. PubMed ID: 22582095
[TBL] [Abstract][Full Text] [Related]
13. Engineering cultured insulin-secreting pancreatic B-cell lines.
McClenaghan NH; Flatt PR
J Mol Med (Berl); 1999 Jan; 77(1):235-43. PubMed ID: 9930971
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion.
McClenaghan NH; Barnett CR; Ah-Sing E; Abdel-Wahab YH; O'Harte FP; Yoon TW; Swanston-Flatt SK; Flatt PR
Diabetes; 1996 Aug; 45(8):1132-40. PubMed ID: 8690162
[TBL] [Abstract][Full Text] [Related]
15. Detrimental actions of metabolic syndrome risk factor, homocysteine, on pancreatic beta-cell glucose metabolism and insulin secretion.
Patterson S; Flatt PR; Brennan L; Newsholme P; McClenaghan NH
J Endocrinol; 2006 May; 189(2):301-10. PubMed ID: 16648297
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the role of N-methyl-D-aspartate (NMDA) receptors in insulin secreting beta-cells.
Patterson S; Irwin N; Guo-Parke H; Moffett RC; Scullion SM; Flatt PR; McClenaghan NH
Eur J Pharmacol; 2016 Jan; 771():107-13. PubMed ID: 26688567
[TBL] [Abstract][Full Text] [Related]
17. Influence of neuropeptide Y and pancreatic polypeptide on islet function and beta-cell survival.
Khan D; Vasu S; Moffett RC; Irwin N; Flatt PR
Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):749-758. PubMed ID: 28069397
[TBL] [Abstract][Full Text] [Related]
18. Physiological regulation of the pancreatic {beta}-cell: functional insights for understanding and therapy of diabetes.
McClenaghan NH
Exp Physiol; 2007 May; 92(3):481-96. PubMed ID: 17272356
[TBL] [Abstract][Full Text] [Related]
19. Effects of pharmacological inhibition of NADPH oxidase or iNOS on pro-inflammatory cytokine, palmitic acid or H2O2-induced mouse islet or clonal pancreatic β-cell dysfunction.
Michalska M; Wolf G; Walther R; Newsholme P
Biosci Rep; 2010 Dec; 30(6):445-53. PubMed ID: 20178457
[TBL] [Abstract][Full Text] [Related]
20. Acute and long-term effects of metformin on the function and insulin secretory responsiveness of clonal β-cells.
McKiney JM; Irwin N; Flatt PR; Bailey CJ; McClenaghan NH
Biol Chem; 2010 Dec; 391(12):1451-9. PubMed ID: 20868233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
